主要文件

查看所有文档

P5624

PD-118057

Name: PD-118057
Brand: SIGMA

≥98% (HPLC), solid

别名:

2-[[4-[2-(3,4-Dichlorophenyl)ethyl]phenyl]amino]benzoic acid

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₂₁H₁₇Cl₂NO₂

化学文摘社编号:

313674-97-4

分子量:

386.27

NACRES:

NA.77

PubChem Substance ID:

24724580

UNSPSC Code:

12352200

MDL number:

MFCD08705328

Assay:

≥98% (HPLC)

Form:

solid

Quality level:

100

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

Quality Level

100

assay

≥98% (HPLC)

form

solid

color

light yellow

solubility

DMSO: 9 mg/mL

storage temp.

−20°C

SMILES string

OC(=O)c1ccccc1Nc2ccc(CCc3ccc(Cl)c(Cl)c3)cc2

InChI

1S/C21H17Cl2NO2/c22-18-12-9-15(13-19(18)23)6-5-14-7-10-16(11-8-14)24-20-4-2-1-3-17(20)21(25)26/h1-4,7-13,24H,5-6H2,(H,25,26)

InChI key

ZCQOSCDABPVAFB-UHFFFAOYSA-N

说明

Biochem/physiol Actions

Activator of ether-a-go-go-related (hERG) potassium channel. Used in the treatment of congestive heart failure.

PD-118057 is an activator of ether-a-go-go-related (hERG) potassium channel. PD-118057 is a second identified hERG channel activator, a representative in the series of structural analogs; PD-118057 at 10 μM leads to a 111% current increase in rabbit ventricular wedge (in comparison RPR260243 leads to only a 15% increase at the same concentration);PD-118057, unlike RPR260243, does not have a major effect on gating or kinetic properties of this channel. PD-118057prevents and reverses QT interval prolongation; Compounds such as PD-118057 may offer new approach in the treatment of delayed repolarization conditions, which occur in inherited or acquired long QT syndrome and congestive heart failure

Features and Benefits

This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.